Please login to the form below
heart attack
This page shows the latest heart attack news and features for those working in and with pharma, biotech and healthcare.
BMS and Janssen’s antithrombotic granted FDA fast track designation
For milvexian to receive fast track designation from the FDA for all three indications demonstrates the enormous unmet need that still exists for the treatment of thrombotic events, like heart attack
Latest news
-
NICE recommends wider use of statins to cut risk of heart attack and stroke
people to reduce their risk of having a heart attack or stroke. ... British Heart Foundation medical director, Professor Sir Nilesh Samani, said: "Research has shown that statins are largely safe.
-
Mind the gender gap: how marcomms can tackle gender health inequality
For example:. Women are more likely to experience delays, misdiagnosis and poor treatment in conditions as diverse as cancer, heart disease, chronic pain and dementia. ... For example, there have been recent reports of heart attacks being dismissed as
-
New research shows potential to diagnose myocarditis with routine blood tests
Currently, the gold standard method in diagnosing the condition is a heart biopsy. ... Patients with myocarditis were found to have significantly increased levels of T-cells with cMet on their surface compared to other groups, including heart attack
-
Novartis’ Leqvio shows sustained efficacy and safety for cardiac patients
Unexpected rupture of the atherosclerotic plaque can cause an atherosclerotic cardiovascular event such as a heart attack or stroke, which account for 85% of all cardiovascular disease deaths. ... and director of the National Heart Institute.
-
World Heart Day highlights actions to prevent and control cardiovascular disease
Today’s campaign aims to inform people that, by controlling these risk factors, 80% of premature deaths from heart disease and stroke could be avoided. ... which can double the risk of having a heart attack.
More from news
Approximately 6 fully matching, plus 232 partially matching documents found.
Latest Intelligence
-
The evolution of marketing – the Amgen way
Yet, cardiovascular disease is still the leading cause of death in Europe, and 80% of premature cases of heart disease and stroke are preventable. ... predict which cardiovascular disease patients are at high risk of a second event, such as a heart attack
-
Changing direction: adapting to a rapidly-evolving environment
In the era of the algorithm, your doctor can now predict you’ll have a fatal heart attack five years before it hits you. ... If we’re going to exploit the brilliance of technology to change behaviours and transform health outcomes, marketing and
-
Insights from Cannes Lions Health Festival 2018
sea. He describes the impact – the pain, the chaos and the suffering – and we experience the attack with him through Jaws-style shots. ... The film ends with a big reveal: this wasn’t a shark attack, but a heart attack.
-
Proving real-world value
Insights reach R&D that ordinarily take years; beta-blockers, for example, found expanded use to control hypertension only after retrospective analysis of four decades of use in heart attack patients.”.
-
Why health psychology is the answer to tackling adherence
Therapy (OAP), a treatment that has been shown to reduce the risk of death or non-fatal heart attack.
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
Changing the narrative: women reveal what they want from health communication and health brands
Misdiagnosis is particularly serious when it comes to heart conditions with women more likely to die of a heart attack than men.
-
Women turn to brands for health advice after feeling sidelined by professionals
Misdiagnosis is particularly serious when it comes to heart conditions with women more likely to die of a heart attack than men.
-
Pharmacogenomics supports and new era of precision medicine
Even aspirin, a well-known and common drug, can have varying effects based on a person’s genes, meaning that the often-intended use of reducing risk of heart attack or ... For pharmaceutical companies, it offers a huge opportunity to place the patient
-
Addressing the Gendered Health Data Gap
Take heart attacks for example, the British Heart Foundation found women are 50% more likely to be misdiagnosed following a heart attack. ... One of the routine tests to diagnose a heart attack is the troponin test used to identify damage to heart cells.
-
#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
For example, women experience different symptoms for heart attacks than men. ... It’s likely that this contributes to the fact that women are more likely to die within the first year of having a heart attack.
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
Subscribe to our email news alerts
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- AbbVie’s Rinvoq receives FDA approval for Crohn’s disease
- Bayer’s Nubeqa combination recommended by NICE to treat metastatic prostate cancer
- AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer
- Novo Nordisk announces positive phase 3 results for oral weight-loss drug
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- FDA approves Blueprint Medicines’ Ayvakit for indolent systemic mastocytosis
- Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Gene therapy, gene editing and perspectives on future use in Parkinson’s disease
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- Shining a Spotlight on Women’s Health Education Outcomes at ACOG 2023
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- ...
- Working together to achieve better patient pathways
- Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
- Design-thinking. Iterating for continuous improvement.
- How design can lead improvement within Pharma...
